BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 21520169)

  • 21. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (review).
    Jariwala N; Rajasekaran D; Srivastava J; Gredler R; Akiel MA; Robertson CL; Emdad L; Fisher PB; Sarkar D
    Int J Oncol; 2015 Feb; 46(2):465-73. PubMed ID: 25405367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1.
    He R; Yang L; Lin X; Chen X; Lin X; Wei F; Liang X; Luo Y; Wu Y; Gan T; Dang Y; Chen G
    Int J Clin Exp Pathol; 2015; 8(12):15632-41. PubMed ID: 26884832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Small Inhibitors for Human Metadherin, an Oncoprotein, through
    Khattak AA; Ahmad A; Khattak HA; Irshad Khan MZ
    Curr Comput Aided Drug Des; 2023; 19(4):278-287. PubMed ID: 36627784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HBx elevates oncoprotein AEG-1 expression to promote cell migration by downregulating miR-375 and miR-136 in malignant hepatocytes.
    Zhao J; Wang W; Huang Y; Wu J; Chen M; Cui P; Zhang W; Zhang Y
    DNA Cell Biol; 2014 Oct; 33(10):715-22. PubMed ID: 25050974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic deletion of AEG-1 prevents hepatocarcinogenesis.
    Robertson CL; Srivastava J; Siddiq A; Gredler R; Emdad L; Rajasekaran D; Akiel M; Shen XN; Guo C; Giashuddin S; Wang XY; Ghosh S; Subler MA; Windle JJ; Fisher PB; Sarkar D
    Cancer Res; 2014 Nov; 74(21):6184-93. PubMed ID: 25193383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug resistance mediated by AEG-1/MTDH/LYRIC.
    Meng X; Thiel KW; Leslie KK
    Adv Cancer Res; 2013; 120():135-57. PubMed ID: 23889990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The microRNA effector RNA-induced silencing complex in hidradenitis suppurativa: a significant dysregulation within active inflammatory lesions.
    Hessam S; Sand M; Skrygan M; Bechara FG
    Arch Dermatol Res; 2017 Sep; 309(7):557-565. PubMed ID: 28634830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of genes conferring resistance to 5-fluorouracil.
    Yoo BK; Gredler R; Vozhilla N; Su ZZ; Chen D; Forcier T; Shah K; Saxena U; Hansen U; Fisher PB; Sarkar D
    Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12938-43. PubMed ID: 19622726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PABPC1 interacts with AGO2 and is responsible for the microRNA mediated gene silencing in high grade hepatocellular carcinoma.
    Zhang H; Sheng C; Yin Y; Wen S; Yang G; Cheng Z; Zhu Q
    Cancer Lett; 2015 Oct; 367(1):49-57. PubMed ID: 26188282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
    Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.
    Wan L; Lu X; Yuan S; Wei Y; Guo F; Shen M; Yuan M; Chakrabarti R; Hua Y; Smith HA; Blanco MA; Chekmareva M; Wu H; Bronson RT; Haffty BG; Xing Y; Kang Y
    Cancer Cell; 2014 Jul; 26(1):92-105. PubMed ID: 24981741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer.
    Kuruma H; Kamata Y; Takahashi H; Igarashi K; Kimura T; Miki K; Miki J; Sasaki H; Hayashi N; Egawa S
    Am J Pathol; 2009 Jun; 174(6):2044-50. PubMed ID: 19435788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of the human astrocyte elevated gene-1 promoter variants with susceptibility to hepatocellular carcinoma.
    Motalleb G; Gholipour N; Samaei NM
    Med Oncol; 2014 Apr; 31(4):916. PubMed ID: 24659263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astrocyte elevated gene 1 (AEG-1) promotes anoikis resistance and metastasis by inducing autophagy in hepatocellular carcinoma.
    Zhu HD; Liu L; Deng H; Li ZB; Sheng JQ; He XX; Tian DA; Li PY
    J Cell Physiol; 2020 Jun; 235(6):5084-5095. PubMed ID: 31691973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions.
    Blanco MA; Alečković M; Hua Y; Li T; Wei Y; Xu Z; Cristea IM; Kang Y
    J Biol Chem; 2011 Jun; 286(22):19982-92. PubMed ID: 21478147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The emerging role of astrocyte-elevated gene-1 in hepatocellular carcinoma (Review).
    Zhu HD; Liao JZ; He XX; Li PY
    Oncol Rep; 2015 Aug; 34(2):539-46. PubMed ID: 26035424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural insights into the tumor-promoting function of the MTDH-SND1 complex.
    Guo F; Wan L; Zheng A; Stanevich V; Wei Y; Satyshur KA; Shen M; Lee W; Kang Y; Xing Y
    Cell Rep; 2014 Sep; 8(6):1704-1713. PubMed ID: 25242325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration.
    Emdad L; Sarkar D; Su ZZ; Lee SG; Kang DC; Bruce JN; Volsky DJ; Fisher PB
    Pharmacol Ther; 2007 May; 114(2):155-70. PubMed ID: 17397930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.
    Calvisi DF; Simile MM; Ladu S; Frau M; Evert M; Tomasi ML; Demartis MI; Daino L; Seddaiu MA; Brozzetti S; Feo F; Pascale RM
    Hepatology; 2011 Apr; 53(4):1226-36. PubMed ID: 21480327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.